Community Contributor
Member since 2026
Views2.5kTotal number of views
Followers15Total number of followers
Comments0Total number of comments
Subscribers0Total number of subscribers

Economics student and self-taught investor focused on high-growth equities and pipeline-stage pharmaceuticals. I look for businesses where the real story hasn't been priced in yet. Based in Brisbane, Australia.

No link added
US$1.48k
36.7% undervalued intrinsic discount
Fair Value
Revenue
18% p.a.
Profit Margin
31.67%
Future PE
39.15x
Price in 2031
US$2.12k